Hongjing Gu

State Key Laboratory Of Pathogens And Biosecurity
Beijing, 100071, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Multi-Component Protein Vaccine Induces a Strong and Long-Term Immune Response Against Monkeypox Virus.

Multi-Component Protein Vaccine Induces a Strong and Long-Term Immune Response Against Monkeypox Virus.

Journal: Vaccines
Published: November 14, 2024

Intranasal inoculation of female BALB/c mice with replication-deficient human adenovirus type 5 expressing SARS-CoV-2 nucleocapsid protein aggravates lung pathology upon re-encountering the antigen.

Intranasal inoculation of female BALB/c mice with replication-deficient human adenovirus type 5 expressing SARS-CoV-2 nucleocapsid protein aggravates lung pathology upon re-encountering the antigen.

Journal: Virus research
Published: May 29, 2023

A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection.

A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection.

Journal: Frontiers in microbiology
Published: February 27, 2023

Acinetobacter baumannii adaptation to the host pH microenvironment is mediated by allelic variation in a single residue of BauA protein.

Acinetobacter baumannii adaptation to the host pH microenvironment is mediated by allelic variation in a single residue of BauA protein.

Journal: PNAS nexus
Published: August 06, 2022

The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection.

The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection.

Journal: Journal of medical virology
Published: May 10, 2022

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants.

An updated RBD-Fc fusion vaccine booster increases neutralization of SARS-CoV-2 Omicron variants.

Journal: Signal transduction and targeted therapy
Published: May 10, 2022

A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults.

A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults.

Journal: Clinical and translational medicine
Published: April 30, 2022

Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro.

Naphthoquine: A Potent Broad-Spectrum Anti-Coronavirus Drug In Vitro.

Journal: Molecules (Basel, Switzerland)
Published: December 28, 2021

Wide-Range, Rapid, and Specific Identification of Pathogenic Bacteria by Surface-Enhanced Raman Spectroscopy.

Wide-Range, Rapid, and Specific Identification of Pathogenic Bacteria by Surface-Enhanced Raman Spectroscopy.

Journal: ACS sensors
Published: July 20, 2021

Transient acquisition of cross-species infectivity during the evolution of SARS-CoV-2.

Transient acquisition of cross-species infectivity during the evolution of SARS-CoV-2.

Journal: National science review
Published: June 26, 2021

Large-Sized Graphene Oxide Nanosheets Increase DC-T-Cell Synaptic Contact and the Efficacy of DC Vaccines against SARS-CoV-2.

Large-Sized Graphene Oxide Nanosheets Increase DC-T-Cell Synaptic Contact and the Efficacy of DC Vaccines against SARS-CoV-2.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: April 01, 2021

Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice.

Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice.

Journal: Cellular & molecular immunology
Published: February 07, 2021
Showing 1-12 of 33

Last Updated: 09/26/2026